Som Mukherjee
Som Mukherjee
Associate Professor, McMaster University
Verified email at hhsc.ca
Title
Cited by
Cited by
Year
Abiraterone in metastatic prostate cancer without previous chemotherapy
CJ Ryan, MR Smith, JS De Bono, A Molina, CJ Logothetis, P De Souza, ...
New England Journal of Medicine 368 (2), 138-148, 2013
23352013
Adjuvant therapy for completely resected stage II colon cancer
A Figueredo, ME Coombes, S Mukherjee
Cochrane Database of Systematic Reviews, 2008
3232008
Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus
LL Swystun, S Mukherjee, PC Liaw
Journal of Thrombosis and Haemostasis 9 (11), 2313-2321, 2011
1312011
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate …
F Saad, S Hotte, S North, B Eigl, K Chi, P Czaykowski, L Wood, M Pollak, ...
Clinical Cancer Research 17 (17), 5765-5773, 2011
1302011
Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial
PJ Goodwin, RJ Segal, M Vallis, JA Ligibel, GR Pond, A Robidoux, ...
Journal of clinical oncology 32 (21), 2231-2239, 2014
1272014
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study
YJ Ko, CM Canil, SD Mukherjee, E Winquist, C Elser, A Eisen, ...
The lancet oncology 14 (8), 769-776, 2013
1272013
Effect of metformin vs placebo on weight and metabolic factors in NCIC CTG MA. 32
PJ Goodwin, WR Parulekar, KA Gelmon, LE Shepherd, JA Ligibel, ...
Journal of the National Cancer Institute 107 (3), djv006, 2015
972015
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
SS Sridhar, E Winquist, A Eisen, SJ Hotte, E McWhirter, IF Tannock, ...
Investigational new drugs 29 (5), 1045-1049, 2011
972011
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative …
TJ Whelan, JA Julian, TS Berrang, DH Kim, I Germain, AM Nichol, M Akra, ...
The Lancet 394 (10215), 2165-2172, 2019
742019
Is red meat intake a risk factor for breast cancer among premenopausal women?
VH Taylor, M Misra, SD Mukherjee
Breast cancer research and treatment 117 (1), 1-8, 2009
732009
A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer …
KN Chi, EY Yu, C Jacobs, J Bazov, C Kollmannsberger, CS Higano, ...
Annals of Oncology 27 (6), 1116-1122, 2016
612016
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label …
KN Chi, CS Higano, B Blumenstein, JM Ferrero, J Reeves, S Feyerabend, ...
The lancet oncology 18 (4), 473-485, 2017
582017
Improvements in radiographic progression-free survival stratified by ERG gene status in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
G Attard, JS De Bono, CJ Logothetis, K Fizazi, SD Mukherjee, AM Joshua, ...
Clinical cancer research 21 (7), 1621-1627, 2015
542015
Physician‐related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients
MA O’Brien, PM Ellis, TJ Whelan, C Charles, A Gafni, P Lovrics, ...
Health Expectations 16 (4), 373-384, 2013
452013
Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium
SS Sridhar, MJ Mackenzie, SJ Hotte, SD Mukherjee, C Kollmannsberger, ...
Journal of Clinical Oncology 26 (15_suppl), 5047-5047, 2008
422008
Cardiac complications associated with checkpoint inhibition: a systematic review of the literature in an important emerging area
H Mir, M Alhussein, S Alrashidi, H Alzayer, A Alshatti, N Valettas, ...
Canadian Journal of Cardiology 34 (8), 1059-1068, 2018
412018
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer
EK Beardsley, SJ Hotte, S North, SL Ellard, E Winquist, ...
Investigational new drugs 30 (4), 1652-1659, 2012
412012
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)
P Moretto, L Wood, U Emmenegger, N Blais, SD Mukherjee, E Winquist, ...
Canadian Urological Association Journal 7 (1-2), E44, 2013
392013
Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients
SD Mukherjee, LL Swystun, N Mackman, JG Wang, G Pond, MN Levine, ...
Pathophysiology of haemostasis and thrombosis 37 (2-4), 88-97, 2010
352010
Hypoxia-induced lactate dehydrogenase expression and tumor angiogenesis
SM Colgan, S Mukherjee, P Major
Clinical colorectal cancer 6 (6), 442-446, 2007
342007
The system can't perform the operation now. Try again later.
Articles 1–20